OVID

Ovid Therapeutics Inc

2.760

+0.150+5.75%

After Hours: 2.770 +0.010 +0.36%19:19 07/07 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE2.640/2.610

TODAY RANGE2.490-2.820

VOL3.31M

MARKET CAP515.13M

52 WEEK RANGE0.3305-3.105

AVG VOL (3M)2.70M

% TURNOVER1.78%

TURNOVER--

P/E (TTM)-11.3394

% RANGE12.64%

EPS(TTM)-0.2434

P/E(FORWARD)-6.1333

P/B2.329

BVPS1.185

DIVIDEND--

P/S49.55

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP479.14M

SHARES OUTSTANDING186.64M

NEXT EARNINGS08/11-08/17

FREE FLOAT173.60M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

Seeking Alpha·3h ago
Ovid Therapeutics: Risk-Adjusted Valuation Shows Deep Discount Despite 700% Rally
Seeking Alpha·8h ago
Ovid Therapeutics: Buy Next-Gen GABA-Aminotransferase Inhibitor OV329 And TSC/IS Expansions
PUBT·06/17 20:20
Ovid Therapeutics director Anna Greka files initial beneficial ownership statement
TipRanks·06/11 13:26
Ovid Therapeutics Shareholders Back Board and Governance Proposals
PUBT·06/11 13:03
Ovid Therapeutics shareholders approve executive pay advisory proposal at annual meeting
TipRanks·06/08 17:30
Analysts Offer Insights on Healthcare Companies: Voyager Therapeutics (VYGR), Ovid Therapeutics (OVID) and Establishment Labs Holdings (ESTA)
PUBT·06/04 11:04
Ovid Therapeutics to present at Oppenheimer CNS & Neuro-Muscular Summit
TipRanks·06/03 13:51
Ovid Therapeutics Expands Board, Appoints New Scientific Director
PUBT·06/03 11:03
Ovid Therapeutics names Anna Greka to board of directors
Dow Jones·06/03 11:03
*Ovid Therapeutics Appoints Anna Greka to Board of Directors
Reuters·06/03 11:00
OVID THERAPEUTICS APPOINTS LEADING PHYSICIAN-SCIENTIST AND BIOTECH INNOVATOR ANNA GREKA, M.D., PH.D., TO BOARD OF DIRECTORS
Dow Jones·06/03 11:00
Press Release: Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors
TipRanks·05/26 10:36
Ovid Therapeutics: Advancing Seizure Pipeline and Neuropsychiatric Programs Support Buy Rating and Unchanged $4 Price Target
TipRanks·05/14 14:49
Ovid Therapeutics price target raised to $7 from $5 at Roth Capital
TipRanks·05/14 10:40
Analysts’ Top Healthcare Picks: GRI Bio (GRI), Ovid Therapeutics (OVID)

Same Industry

Name/Symbol

Change%

Price

OVID

Regeneron Pharmaceuticals

REGN

+2.06%

632.90

GridAI Tech

GRDX

+5.16%

4.690

BIONTECH

BNTX

+1.36%

91.22

United Therapeutics Corp.

UTHR

-1.56%

547.25

Vertex Pharmaceuticals Inc

VRTX

-0.58%

496.73

Siga Technologie

SIGA

-0.76%

3.920

Moderna

MRNA

+0.47%

70.03

Charles Riv Labs Intl Inc

CRL

+1.43%

215.75

Medpace Holdings

MEDP

+2.13%

555.14

Talphera Inc

TLPH

-1.90%

1.030

ICON plc

ICLR

+5.53%

169.86

China Biologic

CBPO

0.00%

119.99

Iqvia Hldgs Inc

IQV

+1.89%

207.04

MOLECULAR PARTNERS AG

MOLN

0.00%

4.000

Arcturus Therape

ARCT

+11.90%

7.71

Gilead Sciences Inc

GILD

+4.21%

131.27

PRA Health

PRAH

0.00%

165.21

Incyte Corp

INCY

-1.13%

113.36

Aptevo Therapeutics Inc

APVO

+0.89%

4.510

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.